ACTR-23. COMBINED IMMUNOCHEMOTHERAPY, R-MPV-A, WITH REDUCED OR DEFERRED RADIOTHERAPY FOR PCNSL IMPROVES SURVIVAL WITH FAVORABLE PERFORMANCE AND COGNITIVE FUNCTION | Zendy

AI Assistant Blog Pricing

ACTR-23. COMBINED IMMUNOCHEMOTHERAPY, R-MPV-A, WITH REDUCED OR DEFERRED RADIOTHERAPY FOR PCNSL IMPROVES SURVIVAL WITH FAVORABLE PERFORMANCE AND COGNITIVE FUNCTION

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.